Billionaires Holding ACAD

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 99.8M
    Shares Outstanding

  • 4.02B
    Market Cap

News & Insights

ABOUT

ACAD

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. The company has a pipeline of product candidates led by Pimavanserin th...

Buffett's key to investing: Four stocks that show a durable competitive advantage

NEWS

Icahn Enterprises launches tender offer for Federal-Mogul shares at 5.6% discount

READ MORE